- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | EXTRAWELL PHAR (00858): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| Mi | EXTRAWELL PHAR (00858): COMPLETION OF ISSUE OF NEW SHARES UNDER GENERAL MANDATE AND BUSINESS UPDATE | - | HKEx | ||
| 22.08. | EXTRAWELL PHAR (00858): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 AUGUST 2025 | 2 | HKEx | ||
| 15.08. | EXTRAWELL PHAR (00858): ISSUE OF NEW SHARES UNDER GENERAL MANDATE | 1 | HKEx | ||
| 28.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2025, CIRCULAR DATED 29 ... | 1 | HKEx | ||
| EXTRAWELL PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 28.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2025, CIRCULAR DATED 29 ... | 1 | HKEx | ||
| 28.07. | EXTRAWELL PHAR (00858): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 28.07. | EXTRAWELL PHAR (00858): FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 22 AUGUST 2025 AT 11:00 A.M. | - | HKEx | ||
| 28.07. | EXTRAWELL PHAR (00858): PROPOSALS FOR GENERAL MANDATES TO ISSUE NEW SHARES AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL ... | 1 | HKEx | ||
| 28.07. | EXTRAWELL PHAR (00858): ANNUAL REPORT 2025 | 3 | HKEx | ||
| 03.07. | EXTRAWELL PHAR (00858): TERMS OF REFERENCE OF NOMINATION COMMITTEE | 1 | HKEx | ||
| 30.06. | EXTRAWELL PHAR (00858): ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2025 | 1 | HKEx | ||
| 23.06. | EXTRAWELL PHAR (00858): PROFIT ALERT | - | HKEx | ||
| 17.06. | EXTRAWELL PHAR (00858): DATE OF BOARD MEETING | - | HKEx | ||
| 28.03. | EXTRAWELL PHAR (00858): POLL RESULTS OF THE SPECIAL GENERAL MEETING HELD ON 28 MARCH 2025 | - | HKEx |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 51,42 | -1,00 % | Ionis pharmaceuticals celebrates 10 years of adaptive event for rare diseases | ||
| CSPC PHARMA | 1,096 | -4,74 % | CSPC Pharmaceutical Group-Aktie kann sich nicht behaupten: Kurs fällt um 6,78 Prozent (1,1135 €) | Keinen Grund zur Freude haben Aktionäre der CSPC Pharmaceutical Group : Der Titel verliert deutlich an Wert. Ein Abschlag von 6,78 Prozent zeigt die Kurstafel für die CSPC Pharmaceutical Group-Aktie... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,442 | +0,70 % | SELLAS Life Sciences Group, Inc. - 8-K, Current Report | ||
| ACADIA PHARMACEUTICALS | 20,120 | -4,10 % | TD Cowen hebt Kursziel für Acadia Pharmaceuticals auf 39 US-Dollar an | ||
| MADRIGAL PHARMACEUTICALS | 368,80 | +1,88 % | A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 6 Analysts | ||
| CATALYST PHARMACEUTICALS | 16,935 | +0,83 % | Catalyst Pharmaceuticals auf Baird-Konferenz: Strategischer Fokus auf Wachstum bei seltenen Krankheiten | ||
| ENZON PHARMACEUTICALS | 0,055 | 0,00 % | Enzon Pharmaceuticals, Inc: Enzon and Viskase Enter into Merger Agreement | CRANFORD, N.J. and LOMBARD, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQX: ENZN) ("Enzon" or the "Company") and Viskase Companies, Inc. (OTC Pink Limited: VKSC) ("Viskase")... ► Artikel lesen | |
| OPUS GENETICS | 1,184 | +2,42 % | Opus Genetics, Inc.: Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - August 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,090 | 0,00 % | NSE - Viracta Therapeutics, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| SAVARA | 3,080 | +0,65 % | Guggenheim raises Savara stock price target to $11 on manufacturing updates | ||
| GALECTIN THERAPEUTICS | 3,940 | +2,60 % | Galectin Therapeutics Inc.: Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update | NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results... ► Artikel lesen | |
| BIODEXA PHARMACEUTICALS | 6,060 | 0,00 % | Biodexa Pharmaceuticals PLC: Interim results for the six months ended June 30, 2025 | September 12, 2025 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Interim results for the six months ended June 30, 2025 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical... ► Artikel lesen | |
| NOVABAY PHARMACEUTICALS | 2,725 | 0,00 % | Stocks Moving Premarket: NovaBay Pharmaceuticals, Auddia, Propanc Biopharma And Other Gainers & Losers | CANBERA (dpa-AFX) - At 7:15 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NEURIZON THERAPEUTICS | 0,073 | 0,00 % | XFRA ECQ0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNEURIZON THERAPEUTICS... ► Artikel lesen |
Das Unternehmen EXTRAWELL PHARMACEUTICAL HOLDINGS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXTRAWELL PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.